What Is Empaveli, and Why Does It Matter? First approved in 2021 for a rare blood disorder, Empaveli (pegcetacoplan) is now approved as the first targeted medicine for adults and children aged 12 ...
Mar. 12, 2026 -- While heart disease may be the number-one killer in the United States, kidney disease is the silent partner we rarely discuss. It often develops quietly, with no pain or clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results